Imperial Prostate

14/10/2025

is a pivotal randomised controlled trial for men with prostate cancer on active surveillance, comparing the UK NICE-guided standard of care VS a regular MRI-based active surveillance pathway

🚀 Our aim: to determine which strategy better detects prostate cancer progression over 5 years

🌟 A tremendous effort from our 🔟 participating sites has been made to already open and recruit over 145 patients from across the country!

Thank you to NIHR (National Institute for Health and Care Research) HTA for funding this and to all our investigators, research teams and participants driving this trial forward!

🏥 Interested in changing practice? New sites welcome — join us!
✉️ atlas@imperial.ac.uk

06/10/2025

TRANSFORM IS COMING!

The TRANSFORM Co-Leads and Trial Management Group met last week for the final face to face meeting before the study kicks off.

TRANSFORM will provide the definitive evidence that the UK National Screening Committee needs before it can make a recommendation on screening for prostate cancer. Organising a national screening trial is a huge undertaking - which is why the study team includes some of the best minds in the country with a wealth of experience.

It is absolutely critical that we get this trial right so we can provide the answers that so many men and their families are looking for.

Thank you to all of our co-investigators for the incredible amount of time and effort you have put in to get us to this point, and especially to our funders Prostate Cancer UK and National Institute for Health and Care Research for supporting this important trial.

03/10/2025

With the prostate cancer screening trial getting started, it is imperative that we can offer a treatment that improves the balance between the harms and benefits of treating localised prostate cancer.

“aims to spare men the incontinence, impotence and even pe**le shortening that have made treating the disease one of the most controversial and polarizing fields in medicine.”

Read the latest interview with Prof Hashim Uddin Ahmed in Bloomberg: https://lnkd.in/eM3feVzH

Imperial College Healthcare NHS Trust Imperial College London

This link will take you to a page that’s not on LinkedIn

29/09/2025

👏 A final robotic prostatectomy for our NIHR Clinical Lecturer Mr Martin J Connor under the mentorship of our senior robotic prostate surgeon Mr Mathias Winkler and assisted by our amazing robotic theatre nursing team at Charing Cross Hospital (Imperial College Healthcare NHS Trust).

Wishing him all the best as he moves clinically to The Royal Marsden Hospital.